Duke University Medical Center; Oncology

Durham, North Carolina 27710

0 studies enrolling now · 2 studies all time

What they study most

Hepatic Impairment, Melanoma

Studies at this site

• INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function — Completed
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed